Answers are grounded in this paper and cite their sources.
Demonstrates high diagnostic accuracy for triple-negative breast cancer using ultratrace plasma proteomics, implying a breakthrough in noninvasive diagnostics.
Blood-based proteomics holds great promise for noninvasive disease diagnostics, yet remains constrained by large sample requirements, laborious preprocessing, and limited sensitivity. Here, we present a streamlined workflow for ultratrace plasma sample proteomics (UPSP) utilizing boronic acid-functionalized metal–organic frameworks (MOFs) that enable efficient protein enrichment from just 1 μL plasma through synergistic nitrogen–boronate complexation, cation−π interaction, and O–Eu coordination. UPSP eliminates the need for high-abundance protein depletion and peptide fractionation, achieving robust and reproducible quantification of over 500 proteins per microliter with high interassay precision ( R 2 = 0.986) and low variability (CV < 20% for >65% of proteins). We demonstrate the utility of UPSP in a clinical context by profiling plasma from triple-negative breast cancer (TNBC) and healthy controls. Integrated with machine learning, the platform achieved a diagnostic accuracy of 0.93 for TNBC. UPSP provides a versatile and scalable platform for deep proteome profiling of trace-volume biospecimens, with broad applicability in biomarker discovery, longitudinal monitoring, and scarce-sample scenarios.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: